O	O	0	12	Constitutive	Constitutive	B-NP	JJ	O	3	NMOD	O
O	O	13	23	expression	expression	I-NP	NN	O	3	NMOD	O
T1	B-Protein	24	25	c	c	I-NP	NN	O	15	NMOD	O
T1	I-Protein	25	26	-	-	B-NP	HYPH	O	5	NMOD	O
T1	I-Protein	26	29	fos	fos	I-NP	NN	O	15	NMOD	O
O	O	29	30	,	,	O	,	O	15	P	O
T2	B-Protein	31	32	c	c	B-NP	NN	B-DNA	9	NMOD	B-DNA
T2	I-Protein	32	33	-	-	I-NP	HYPH	I-DNA	9	NMOD	I-DNA
T2	I-Protein	33	36	jun	jun	I-NP	NN	I-DNA	15	NMOD	I-DNA
O	O	36	37	,	,	O	,	O	15	P	O
O	O	38	41	and	and	O	CC	O	15	NMOD	O
O	O	42	44	NF	NF	B-NP	NN	B-RNA	15	NMOD	B-RNA
O	O	45	50	kappa	kappa	I-NP	NN	I-RNA	15	NMOD	I-RNA
O	O	51	52	B	B	I-NP	NN	I-RNA	15	NMOD	I-RNA
O	O	53	57	mRNA	mRNA	I-NP	NN	I-RNA	16	SUB	I-RNA
O	O	58	60	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	61	63	in	in	B-PP	IN	O	16	PRD	O
O	O	64	73	nucleated	nucleated	B-NP	JJ	B-cell_type	21	NMOD	B-cell_type
O	O	74	79	fetal	fetal	I-NP	JJ	I-cell_type	21	NMOD	I-cell_type
O	O	80	85	blood	blood	I-NP	NN	I-cell_type	21	NMOD	I-cell_type
O	O	86	91	cells	cell	I-NP	NNS	I-cell_type	17	PMOD	I-cell_type
O	O	92	95	and	and	O	CC	O	16	VMOD	O
O	O	96	98	up	up	B-ADVP	RB	O	25	NMOD	O
O	O	98	99	-	-	B-NP	HYPH	O	23	AMOD	O
O	O	99	109	regulation	regulation	I-NP	NN	O	16	PRD	O
O	O	110	112	of	of	B-PP	IN	O	25	NMOD	O
T3	B-Protein	113	114	c	c	B-NP	NN	B-DNA	29	NMOD	B-DNA
T3	I-Protein	114	115	-	-	I-NP	HYPH	I-DNA	29	NMOD	I-DNA
T3	I-Protein	115	118	fos	fos	I-NP	NN	I-DNA	33	NMOD	I-DNA
O	O	119	122	and	and	I-NP	CC	O	33	NMOD	O
T4	B-Protein	123	124	c	c	I-NP	NN	B-DNA	33	NMOD	B-DNA
T4	I-Protein	124	125	-	-	O	HYPH	I-DNA	33	P	I-DNA
T4	I-Protein	125	128	jun	jun	B-NP	NN	I-DNA	26	PMOD	I-DNA
O	O	129	133	with	with	B-PP	IN	O	33	NMOD	O
O	O	134	138	anti	anti	B-NP	AFX	O	38	NMOD	O
O	O	138	139	-	-	I-NP	HYPH	O	38	NMOD	O
T12	B-Entity	139	142	CD3	CD3	I-NP	NN	B-protein	38	NMOD	B-protein
O	O	143	154	stimulation	stimulation	I-NP	NN	O	34	PMOD	O
O	O	154	155	.	.	O	.	O	16	P	O

O	O	157	162	Fetal	Fetal	B-NP	JJ	B-cell_type	4	NMOD	B-cell_type
O	O	163	166	and	and	I-NP	CC	I-cell_type	4	NMOD	I-cell_type
O	O	167	175	neonatal	neonatal	I-NP	JJ	I-cell_type	4	NMOD	I-cell_type
O	O	176	187	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	5	SUB	I-cell_type
O	O	188	191	are	be	B-VP	VBP	O	0	ROOT	O
O	O	192	202	relatively	relatively	B-ADJP	RB	O	7	AMOD	O
O	O	203	212	resistant	resistant	I-ADJP	JJ	O	5	PRD	O
O	O	213	215	to	to	B-PP	TO	O	7	AMOD	O
O	O	216	226	activation	activation	B-NP	NN	O	12	NMOD	O
O	O	227	230	and	and	O	CC	O	12	NMOD	O
O	O	231	239	cytokine	cytokine	B-NP	NN	B-protein	12	NMOD	B-protein
O	O	240	250	production	production	I-NP	NN	O	8	PMOD	O
O	O	251	255	when	when	B-ADVP	WRB	O	5	VMOD	O
O	O	256	266	stimulated	stimulate	B-VP	VBN	O	13	SBAR	O
O	O	267	273	either	either	B-PP	CC	O	16	PMOD	O
O	O	274	277	via	via	I-PP	IN	O	14	VMOD	O
O	O	278	283	their	their	B-NP	PRP$	O	24	NMOD	O
O	O	284	285	T	T	I-NP	NN	B-protein	22	NMOD	B-protein
O	O	285	286	-	-	I-NP	HYPH	I-protein	22	P	I-protein
O	O	286	290	cell	cell	I-NP	NN	I-protein	22	NMOD	I-protein
O	O	291	298	antigen	antigen	I-NP	NN	I-protein	22	NMOD	I-protein
O	O	299	308	receptors	receptor	I-NP	NNS	I-protein	24	NMOD	I-protein
O	O	309	311	or	or	I-NP	CC	O	24	NMOD	O
O	O	312	319	lectins	lectin	I-NP	NNS	B-protein	16	PMOD	B-protein
O	O	319	320	.	.	O	.	O	5	P	O

O	O	321	324	The	The	B-NP	DT	O	5	NMOD	O
O	O	325	334	molecular	molecular	I-NP	JJ	O	5	NMOD	O
O	O	335	344	mechanism	mechanism	I-NP	NN	O	5	NMOD	O
O	O	344	345	(	(	I-NP	(	O	5	NMOD	O
O	O	345	346	s	s	I-NP	NNS	O	11	SUB	O
O	O	346	347	)	)	O	)	O	5	NMOD	O
O	O	348	359	responsible	responsible	B-ADJP	JJ	O	5	NMOD	O
O	O	360	363	for	for	B-PP	IN	O	7	AMOD	O
O	O	364	368	this	this	B-NP	DT	O	10	NMOD	O
O	O	369	379	phenomenon	phenomenon	I-NP	NN	O	8	PMOD	O
O	O	380	384	have	have	B-VP	VBP	O	0	ROOT	O
O	O	385	388	not	not	I-VP	RB	O	11	VMOD	O
O	O	389	393	been	be	I-VP	VBN	O	11	VC	O
O	O	394	401	clearly	clearly	I-VP	RB	O	13	VMOD	O
O	O	402	412	elucidated	elucidate	I-VP	VBN	O	13	VC	O
O	O	412	413	.	.	O	.	O	11	P	O

O	O	414	416	We	We	B-NP	PRP	O	2	SUB	O
O	O	417	421	have	have	B-VP	VBP	O	0	ROOT	O
O	O	422	434	hypothesized	hypothesize	I-VP	VBN	O	2	VC	O
O	O	435	439	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	440	444	such	such	B-NP	JJ	O	6	NMOD	O
O	O	445	452	defects	defect	I-NP	NNS	O	15	SUB	O
O	O	453	455	in	in	B-PP	IN	O	6	NMOD	O
O	O	456	461	fetal	fetal	B-NP	JJ	O	14	NMOD	O
O	O	461	462	/	/	I-NP	SYM	O	14	NMOD	O
O	O	462	470	neonatal	neonatal	I-NP	JJ	B-cell_type	14	NMOD	B-cell_type
O	O	471	472	T	T	I-NP	NN	I-cell_type	14	NMOD	I-cell_type
O	O	472	473	-	-	I-NP	HYPH	I-cell_type	14	NMOD	I-cell_type
O	O	473	477	cell	cell	I-NP	NN	I-cell_type	14	NMOD	I-cell_type
O	O	478	488	activation	activation	I-NP	NN	O	7	PMOD	O
O	O	489	492	may	may	B-VP	MD	O	4	SBAR	O
O	O	493	495	be	be	I-VP	VB	O	15	VC	O
O	O	496	499	due	due	B-ADJP	JJ	O	16	PRD	O
O	O	500	502	to	to	B-PP	TO	O	17	AMOD	O
O	O	503	507	lack	lack	B-NP	NN	O	18	PMOD	O
O	O	508	510	of	of	B-PP	IN	O	19	NMOD	O
O	O	511	521	expression	expression	B-NP	NN	O	20	PMOD	O
O	O	522	524	of	of	B-PP	IN	O	21	NMOD	O
O	O	525	528	the	the	B-NP	DT	O	26	NMOD	O
O	O	529	544	transcriptional	transcriptional	I-NP	JJ	B-DNA	26	NMOD	B-DNA
O	O	545	555	regulatory	regulatory	I-NP	JJ	I-DNA	26	NMOD	I-DNA
O	O	556	564	elements	element	I-NP	NNS	I-DNA	22	PMOD	I-DNA
O	O	565	573	required	require	B-VP	VBN	O	26	NMOD	O
O	O	574	577	for	for	B-PP	IN	O	27	VMOD	O
O	O	578	579	T	T	B-NP	NN	B-cell_type	32	NMOD	B-cell_type
O	O	579	580	-	-	B-NP	HYPH	I-cell_type	32	NMOD	I-cell_type
O	O	580	584	cell	cell	I-NP	NN	I-cell_type	32	NMOD	I-cell_type
O	O	585	595	activation	activation	I-NP	NN	O	28	PMOD	O
O	O	595	596	.	.	O	.	O	2	P	O

O	O	597	599	We	We	B-NP	PRP	O	2	SUB	O
O	O	600	604	used	use	B-VP	VBD	O	0	ROOT	O
O	O	605	612	reverse	reverse	B-NP	JJ	B-protein	4	NMOD	B-protein
O	O	613	626	transcriptase	transcriptase	I-NP	NN	I-protein	8	NMOD	I-protein
O	O	626	627	-	-	B-NP	HYPH	O	8	NMOD	O
O	O	627	637	polymerase	polymerase	I-NP	NN	O	8	NMOD	O
O	O	638	643	chain	chain	I-NP	NN	O	8	NMOD	O
O	O	644	652	reaction	reaction	I-NP	NN	O	2	OBJ	O
O	O	653	655	to	to	B-VP	TO	O	10	VMOD	O
O	O	656	663	examine	examine	I-VP	VB	O	2	VMOD	O
O	O	664	668	both	both	O	CC	O	17	NMOD	O
O	O	669	674	fetal	fetal	O	JJ	O	17	NMOD	O
O	O	675	678	and	and	O	CC	O	17	NMOD	O
O	O	679	683	term	term	B-NP	NN	O	15	AMOD	O
O	O	684	692	neonatal	neonatal	I-NP	JJ	O	17	NMOD	O
O	O	693	697	cord	cord	I-NP	NN	O	17	NMOD	O
O	O	698	704	bloods	blood	I-NP	NNS	O	10	OBJ	O
O	O	705	708	for	for	B-PP	IN	O	17	NMOD	O
O	O	709	713	mRNA	mRNA	B-NP	NN	O	20	NMOD	O
O	O	714	724	expression	expression	I-NP	NN	O	18	PMOD	O
O	O	725	727	of	of	B-PP	IN	O	20	NMOD	O
O	O	728	733	three	three	B-NP	CD	O	21	PMOD	O
O	O	734	747	transcription	transcription	I-NP	NN	B-protein	24	NMOD	B-protein
O	O	748	755	factors	factor	I-NP	NNS	I-protein	22	NMOD	I-protein
O	O	756	766	implicated	implicate	B-VP	VBN	O	22	NMOD	O
O	O	767	769	in	in	B-PP	IN	O	25	VMOD	O
O	O	770	771	T	T	B-NP	NN	B-cell_type	30	NMOD	B-cell_type
O	O	771	772	-	-	B-NP	HYPH	I-cell_type	30	NMOD	I-cell_type
O	O	772	776	cell	cell	I-NP	NN	I-cell_type	30	NMOD	I-cell_type
O	O	777	787	activation	activation	I-NP	NN	O	26	PMOD	O
O	O	787	788	:	:	O	:	O	2	P	O
T5	B-Protein	789	790	c	c	B-NP	NN	B-DNA	34	NMOD	B-DNA
T5	I-Protein	790	791	-	-	O	:	I-DNA	34	P	I-DNA
T5	I-Protein	791	794	jun	jun	B-NP	NN	I-DNA	43	NMOD	I-DNA
O	O	794	795	,	,	I-NP	,	O	43	P	O
T6	B-Protein	796	797	c	c	I-NP	NN	B-DNA	38	NMOD	B-DNA
T6	I-Protein	797	798	-	-	I-NP	HYPH	I-DNA	38	NMOD	I-DNA
T6	I-Protein	798	801	fos	fos	I-NP	NN	I-DNA	43	NMOD	I-DNA
O	O	801	802	,	,	O	,	O	43	P	O
O	O	803	806	and	and	O	CC	O	43	NMOD	O
T13	B-Entity	807	809	NF	NF	B-NP	NN	B-protein	43	NMOD	B-protein
T13	I-Entity	810	815	kappa	kappa	I-NP	NN	I-protein	43	NMOD	I-protein
T13	I-Entity	816	817	B	B	I-NP	NN	I-protein	2	VMOD	I-protein
O	O	818	819	(	(	O	(	O	47	DEP	O
T7	B-Protein	819	822	p50	p50	B-NP	NN	B-protein	46	NMOD	B-protein
O	O	823	830	subunit	subunit	I-NP	NN	I-protein	47	DEP	I-protein
O	O	830	831	)	)	O	)	O	43	NMOD	O
O	O	831	832	.	.	O	.	O	2	P	O

O	O	833	835	We	We	B-NP	PRP	O	2	SUB	O
O	O	836	847	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT	O
O	O	848	852	that	that	B-SBAR	IN	O	2	VMOD	O
O	O	853	858	mRNAs	mRNA	B-NP	NNS	B-RNA	12	SUB	B-RNA
O	O	859	862	for	for	B-PP	IN	O	4	NMOD	O
O	O	863	866	all	all	B-NP	DT	O	7	NMOD	O
O	O	867	872	three	three	I-NP	CD	O	5	PMOD	O
O	O	873	875	of	of	B-PP	IN	O	7	NMOD	O
O	O	876	881	these	these	B-NP	DT	O	11	NMOD	O
O	O	882	892	regulatory	regulatory	I-NP	JJ	B-protein	11	NMOD	B-protein
O	O	893	900	factors	factor	I-NP	NNS	I-protein	8	PMOD	I-protein
O	O	901	904	are	be	B-VP	VBP	O	3	SBAR	O
O	O	905	914	expressed	express	I-VP	VBN	O	12	VC	O
O	O	915	917	in	in	B-PP	IN	O	13	VMOD	O
O	O	918	923	fetal	fetal	B-NP	JJ	B-cell_type	17	NMOD	B-cell_type
O	O	924	929	blood	blood	I-NP	NN	I-cell_type	17	NMOD	I-cell_type
O	O	930	935	cells	cell	I-NP	NNS	I-cell_type	14	PMOD	I-cell_type
O	O	936	938	by	by	B-PP	IN	O	13	VMOD	O
O	O	939	942	the	the	B-NP	DT	O	21	NMOD	O
O	O	943	947	27th	27th	I-NP	JJ	O	21	NMOD	O
O	O	948	952	week	week	I-NP	NN	O	18	PMOD	O
O	O	953	955	of	of	B-PP	IN	O	21	NMOD	O
O	O	956	965	gestation	gestation	B-NP	NN	O	22	PMOD	O
O	O	966	969	and	and	B-PP	CC	O	18	PMOD	O
O	O	970	972	in	in	B-PP	IN	O	18	PMOD	O
O	O	973	977	term	term	B-NP	NN	O	28	NMOD	O
O	O	978	982	cord	cord	I-NP	NN	O	28	NMOD	O
O	O	983	989	bloods	blood	I-NP	NNS	O	25	PMOD	O
O	O	989	990	.	.	O	.	O	2	P	O

O	O	991	1001	Activation	Activation	B-NP	NN	O	15	SUB	O
O	O	1002	1004	of	of	B-PP	IN	O	1	NMOD	O
O	O	1005	1009	term	term	B-NP	NN	B-cell_type	8	NMOD	B-cell_type
O	O	1010	1016	infant	infant	I-NP	NN	I-cell_type	8	NMOD	I-cell_type
O	O	1017	1021	cord	cord	I-NP	NN	I-cell_type	8	NMOD	I-cell_type
O	O	1022	1027	blood	blood	I-NP	NN	I-cell_type	8	NMOD	I-cell_type
O	O	1028	1039	mononuclear	mononuclear	I-NP	JJ	I-cell_type	8	NMOD	I-cell_type
O	O	1040	1045	cells	cell	I-NP	NNS	I-cell_type	2	PMOD	I-cell_type
O	O	1046	1050	with	with	B-PP	IN	O	1	NMOD	O
O	O	1051	1055	anti	anti	B-NP	AFX	O	14	NMOD	O
O	O	1055	1056	-	-	I-NP	HYPH	O	14	NMOD	O
T14	B-Entity	1056	1059	CD3	CD3	I-NP	NN	B-protein	14	NMOD	B-protein
O	O	1060	1070	monoclonal	monoclonal	I-NP	JJ	I-protein	14	NMOD	I-protein
O	O	1071	1081	antibodies	antibody	I-NP	NNS	I-protein	9	PMOD	I-protein
O	O	1082	1090	resulted	result	B-VP	VBD	O	0	ROOT	O
O	O	1091	1093	in	in	B-PP	IN	O	15	VMOD	O
O	O	1094	1096	up	up	B-ADVP	RB	O	18	AMOD	O
O	O	1096	1097	-	-	O	HYPH	O	16	PMOD	O
O	O	1097	1107	regulation	regulation	B-NP	NN	O	18	NMOD	O
O	O	1108	1110	of	of	B-PP	IN	O	19	NMOD	O
O	O	1111	1115	both	both	O	CC	O	29	NMOD	O
T8	B-Protein	1116	1117	c	c	B-NP	NN	B-DNA	29	NMOD	B-DNA
T8	I-Protein	1117	1118	-	-	O	HYPH	I-DNA	29	P	I-DNA
T8	I-Protein	1118	1121	jun	jun	B-NP	NN	I-DNA	29	NMOD	I-DNA
O	O	1122	1125	and	and	I-NP	CC	O	29	NMOD	O
T9	B-Protein	1126	1127	c	c	I-NP	NN	O	29	NMOD	O
T9	I-Protein	1127	1128	-	-	B-NP	HYPH	O	29	NMOD	O
T9	I-Protein	1128	1131	fos	fos	I-NP	NN	B-RNA	29	NMOD	B-RNA
O	O	1132	1137	mRNAs	mRNA	I-NP	NNS	I-RNA	20	PMOD	I-RNA
O	O	1138	1144	within	within	B-PP	IN	O	19	NMOD	O
O	O	1145	1147	15	15	B-NP	CD	O	32	NMOD	O
O	O	1148	1151	min	min	I-NP	NN	O	30	PMOD	O
O	O	1152	1154	of	of	B-PP	IN	O	32	NMOD	O
O	O	1155	1166	stimulation	stimulation	B-NP	NN	O	33	PMOD	O
O	O	1166	1167	.	.	O	.	O	15	P	O

O	O	1168	1175	However	However	B-ADVP	RB	O	18	VMOD	O
O	O	1175	1176	,	,	O	,	O	18	P	O
O	O	1177	1186	secretion	secretion	B-NP	NN	O	18	SUB	O
O	O	1187	1189	of	of	B-PP	IN	O	3	NMOD	O
T10	B-Protein	1190	1192	IL	IL	B-NP	NN	B-protein	4	PMOD	B-protein
T10	I-Protein	1192	1193	-	-	O	HYPH	I-protein	5	NMOD	I-protein
T10	I-Protein	1193	1194	2	2	B-NP	CD	I-protein	5	NMOD	I-protein
O	O	1195	1197	by	by	B-PP	IN	O	3	NMOD	O
O	O	1198	1202	anti	anti	B-NP	AFX	O	17	NMOD	O
O	O	1202	1203	-	-	I-NP	HYPH	O	17	NMOD	O
T15	B-Entity	1203	1206	CD3	CD3	I-NP	NN	B-protein	17	NMOD	B-protein
O	O	1206	1207	-	-	B-NP	HYPH	O	17	NMOD	O
O	O	1207	1217	stimulated	stimulate	I-NP	VBN	B-cell_type	17	NMOD	B-cell_type
O	O	1218	1222	cord	cord	I-NP	NN	I-cell_type	17	NMOD	I-cell_type
O	O	1223	1228	blood	blood	I-NP	NN	I-cell_type	17	NMOD	I-cell_type
O	O	1229	1240	mononuclear	mononuclear	I-NP	JJ	I-cell_type	17	NMOD	I-cell_type
O	O	1241	1246	cells	cell	I-NP	NNS	I-cell_type	8	PMOD	I-cell_type
O	O	1247	1250	was	be	B-VP	VBD	O	0	ROOT	O
O	O	1251	1256	still	still	I-VP	RB	O	18	VMOD	O
O	O	1257	1264	blunted	blunt	I-VP	VBN	O	18	VC	O
O	O	1265	1273	compared	compare	B-PP	VBN	O	20	VMOD	O
O	O	1274	1278	with	with	B-PP	IN	O	21	PMOD	O
O	O	1279	1286	control	control	B-NP	NN	B-cell_type	24	NMOD	B-cell_type
O	O	1287	1292	cells	cell	I-NP	NNS	I-cell_type	22	PMOD	I-cell_type
O	O	1293	1297	from	from	B-PP	IN	O	24	NMOD	O
O	O	1298	1304	adults	adult	B-NP	NNS	O	25	PMOD	O
O	O	1304	1305	.	.	O	.	O	18	P	O

O	O	1306	1308	We	We	B-NP	PRP	O	2	SUB	O
O	O	1309	1317	conclude	conclude	B-VP	VBP	O	0	ROOT	O
O	O	1318	1322	that	that	B-SBAR	IN	O	2	VMOD	O
O	O	1323	1328	fetal	fetal	B-NP	JJ	B-cell_type	7	NMOD	B-cell_type
O	O	1329	1338	nucleated	nucleated	I-NP	JJ	I-cell_type	7	NMOD	I-cell_type
O	O	1339	1344	blood	blood	I-NP	NN	I-cell_type	7	NMOD	I-cell_type
O	O	1345	1350	cells	cell	I-NP	NNS	I-cell_type	9	SUB	I-cell_type
O	O	1351	1365	constitutively	constitutively	B-ADVP	RB	O	9	VMOD	O
O	O	1366	1373	express	express	B-VP	VBP	O	3	SBAR	O
O	O	1374	1383	important	important	B-NP	JJ	O	11	NMOD	O
T16	B-Entity	1384	1389	genes	gene	I-NP	NNS	O	9	OBJ	O
O	O	1390	1393	for	for	B-PP	IN	O	11	NMOD	O
O	O	1394	1402	cytokine	cytokine	B-NP	NN	B-protein	14	NMOD	B-protein
O	O	1403	1413	regulation	regulation	I-NP	NN	O	12	PMOD	O
O	O	1414	1417	and	and	O	CC	O	9	VMOD	O
O	O	1418	1421	are	be	B-VP	VBP	O	9	VMOD	O
O	O	1422	1426	able	able	B-ADJP	JJ	O	16	PRD	O
O	O	1427	1429	to	to	B-VP	TO	O	19	VMOD	O
O	O	1430	1438	increase	increase	I-VP	VB	O	17	AMOD	O
O	O	1439	1452	intracellular	intracellular	B-NP	JJ	O	21	NMOD	O
O	O	1453	1465	accumulation	accumulation	I-NP	NN	O	19	OBJ	O
O	O	1466	1468	of	of	B-PP	IN	O	21	NMOD	O
O	O	1469	1472	the	the	B-NP	DT	O	24	NMOD	O
O	O	1473	1478	mRNAs	mRNA	I-NP	NNS	B-RNA	22	PMOD	B-RNA
O	O	1479	1482	for	for	B-PP	IN	O	21	NMOD	O
O	O	1483	1488	these	these	B-NP	DT	O	27	NMOD	O
O	O	1489	1496	factors	factor	I-NP	NNS	O	25	PMOD	O
O	O	1497	1499	in	in	B-PP	IN	O	19	VMOD	O
O	O	1500	1508	response	response	B-NP	NN	O	28	PMOD	O
O	O	1509	1511	to	to	B-PP	TO	O	29	NMOD	O
O	O	1512	1516	anti	anti	B-NP	AFX	O	34	NMOD	O
O	O	1516	1517	-	-	I-NP	HYPH	O	34	NMOD	O
T17	B-Entity	1517	1520	CD3	CD3	I-NP	NN	B-protein	34	NMOD	B-protein
O	O	1521	1532	stimulation	stimulation	I-NP	NN	O	30	PMOD	O
O	O	1532	1533	.	.	O	.	O	2	P	O

O	O	1534	1538	Thus	Thus	B-ADVP	RB	O	12	VMOD	O
O	O	1538	1539	,	,	O	,	O	12	P	O
O	O	1540	1551	qualitative	qualitative	B-NP	JJ	O	4	NMOD	O
O	O	1552	1563	differences	difference	I-NP	NNS	O	12	SUB	O
O	O	1564	1566	in	in	B-PP	IN	O	4	NMOD	O
O	O	1567	1570	the	the	B-NP	DT	O	7	NMOD	O
O	O	1571	1579	capacity	capacity	I-NP	NN	O	5	PMOD	O
O	O	1580	1582	to	to	B-VP	TO	O	9	VMOD	O
O	O	1583	1591	regulate	regulate	I-VP	VB	O	7	NMOD	O
O	O	1592	1597	these	these	B-NP	DT	O	11	NMOD	O
O	O	1598	1605	factors	factor	I-NP	NNS	O	9	OBJ	O
O	O	1606	1611	could	could	B-VP	MD	O	0	ROOT	O
O	O	1612	1615	not	not	I-VP	RB	O	12	VMOD	O
O	O	1616	1618	be	be	I-VP	VB	O	12	VC	O
O	O	1619	1624	shown	show	I-VP	VBN	O	14	VC	O
O	O	1625	1627	in	in	B-PP	IN	O	15	VMOD	O
O	O	1628	1633	fetal	fetal	B-NP	JJ	B-cell_type	19	NMOD	B-cell_type
O	O	1634	1639	blood	blood	I-NP	NN	I-cell_type	19	NMOD	I-cell_type
O	O	1640	1645	cells	cell	I-NP	NNS	I-cell_type	16	PMOD	I-cell_type
O	O	1645	1646	.	.	O	.	O	12	P	O

O	O	1647	1659	Quantitative	Quantitative	B-NP	JJ	O	2	NMOD	O
O	O	1660	1671	experiments	experiment	I-NP	NNS	O	15	SUB	O
O	O	1672	1681	comparing	compare	B-VP	VBG	O	2	NMOD	O
O	O	1682	1689	binding	binding	B-NP	NN	O	3	OBJ	O
O	O	1690	1692	of	of	B-PP	IN	O	4	NMOD	O
O	O	1693	1698	these	these	B-NP	DT	O	8	NMOD	O
O	O	1699	1712	transcription	transcription	I-NP	NN	B-protein	8	NMOD	B-protein
O	O	1713	1720	factors	factor	I-NP	NNS	I-protein	5	PMOD	I-protein
O	O	1721	1723	to	to	B-PP	TO	O	4	NMOD	O
O	O	1724	1727	the	the	B-NP	DT	O	14	NMOD	O
T11	B-Protein	1728	1730	IL	IL	I-NP	NN	B-DNA	14	NMOD	B-DNA
T11	I-Protein	1730	1731	-	-	I-NP	HYPH	I-DNA	14	NMOD	I-DNA
T11	I-Protein	1731	1732	2	2	I-NP	CD	I-DNA	14	NMOD	I-DNA
T18	B-Entity	1733	1741	promoter	promoter	I-NP	NN	I-DNA	9	PMOD	I-DNA
O	O	1742	1745	are	be	B-VP	VBP	O	0	ROOT	O
O	O	1746	1755	currently	currently	B-ADVP	RB	O	15	VMOD	O
O	O	1756	1761	under	under	B-PP	IN	O	15	PRD	O
O	O	1762	1775	investigation	investigation	B-NP	NN	O	17	PMOD	O
O	O	1775	1776	.	.	O	.	O	15	P	O
